Shortages of raw materials, increased demand for some drugs and a shrinking pool of suppliers have created a serious shortage of various medications. According to the FDA, the small number of manufacturers means that the actions of one company can significantly affect the drug market. The FDA itself has come under fire for exacerbating the shortage with what some call an overly lengthy inspection process.
Lawmakers have recently proposed legislation that would require drug manufacturers to notify the FDA if they’re running low on drugs to give the agency a chance to find a different drug source.
Read the Whittier Daily News report on drug shortages.
Read more on anesthesia:
–ASA Expresses Support for FDA Research on Pediatric Anesthesia
–ASCA Endorses Legislation Empowering FDA to Help Prevent Drug Shortages
–Anesthesiologist-Turned-Governor Declines Government-Subsidized Health Insurance
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
